Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-28

Clinical Trial Update: Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating bedaquiline-based enhanced post-exposure prophylaxis for leprosy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bedaquiline (bedaquiline)

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Leprosy | Phase 3 | Status: RECRUITING